Androgen signaling is critical for proliferation of prostate cancer cells but cannot be fully inhibited by current androgen deprivation therapies. A study by Xu et al. in this issue of Cancer Cell provides insights into the complexities of androgen signaling in prostate cancer and suggests avenues to target a subset of androgen-sensitive genes.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Apr 7 2009|
ASJC Scopus subject areas
- Cell Biology
- Cancer Research